The FDA is tracking new chemical entity approvals while US government support is being withdrawn.
1 report, 1 independent
Updated Jul 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA is tracking new chemical entity approvals while US government support is being withdrawn.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
TB Alliance
organization
Nothing else this week.
Related events
- FDA approval enables commercial opportunity involving CBRE Group.
- Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.
- The FDA is reviewing drug data and company resubmissions, while also overseeing the functions of the U.S. Department of Health and Human Services.
- Unregulated products are bypassing official government approval processes.
- Both the FDA and the European Medicines Agency govern drug approval processes.
Coverage
Newest first; wire copies grouped- devpolicy.orgA not-for-profit medicine development model to address global health inequities - Devpolicy Blog from the Development Policy Centre